Seizure disorders in pregnancy

International Journal of Gynecology and Obstetrics

Volumn 56, Issue 3, 1997, Pages 279-286

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; FOLIC ACID; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; VALPROIC ACID; VITAMIN K GROUP;

ALOPECIA; ATAXIA; BLOOD CLOTTING DISORDER; CONGENITAL MALFORMATION; DIET SUPPLEMENTATION; DOCTOR PATIENT RELATION; DROWSINESS; DRUG DOSE; EPILEPSY; FEMALE; FETUS MALFORMATION; GINGIVA HYPERPLASIA; HIGH RISK PREGNANCY; HIRSUTISM; HUMAN; LABOR; LEUKOPENIA; LIVER TOXICITY; MEGALOBLASTIC ANEMIA; NEURAL TUBE DEFECT; NYSTAGMUS; PATIENT COUNSELING; PRIORITY JOURNAL; REVIEW; SEIZURE; SLEEP; THROMBOCYTOPENIA; TONIC CLONIC SEIZURE; VAGINAL DELIVERY;

EID: 0030895115     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(97)83388-7     Document Type: Review

References (46)

1. Cramer JA, Jones EE. Reproductive function in epilepsy. Epilepsia 1991;32(Suppl 6):S19-S26 (Level III)
2. Back DJ, Bates M, Bowden A, Breckenridge AM, Hall MJ, Jones H, et al. The interaction of phenobarbital and other anticonvulsants with oral contraceptive steroid therapy. Contraception 1980;22:495-503 (Level III)
3. Coulam CB, Annegers JF. Do anticonvulsants reduce the efficacy of oral contraceptives? Epilepsia 1979;20:519-526 (Level II-3)
4. Janz D, Schmidt D. Anti-epileptic drugs and failure of oral contraceptives. Lancet 1974;1:1113 Level (III)
5. Webber MP, Hauser WA, Ottman R, Annegers JF. Fertility in persons with epilepsy: 1935-1974. Epilepsia 1986;27:746-752 (Level II-3)
6. Dansky LV, Andermann E, Andermann F. Marriage and fertility in epileptic patients. Epilepsia 1980;21:261-271 (Level II-3)
7. Yerby M, Koepsell T, Daling J. Pregnancy complications and outcomes in a cohort of women with epilepsy. Epilepsia 1985:26:631-635 (Level II-2)
8. Knight AH, Rhind EG. Epilepsy and pregnancy: a study of 153 pregnancies in 59 patients. Epilepsia 1975;16:99-110 (Level II-3)
9. Nelson KB, Ellenberg JH. Maternal seizure disorder, outcome of pregnancy, and neurologic abnormalities in the children. Neurology 1982;32:1247-1254 (Level II-2)
10. Källén B. A register study of maternal epilepsy and delivery outcome with special reference to drug use. Acta Neurol Scand 1986;73:253-259 (Level II-2)
11. Mastroiacovo P, Bertollini R, Licata D. Fetal growth in the offspring of epileptic women: results of an Italian multicentric cohort study. Acta Neurol Scand 1988;78:110-114 (Level II-2)
12. Hiilesmaa VK, Bardy A, Teramo K. Obstetric outcome in women with epilepsy. Am J Obstet Gynecol 1985; 152:499-504 (Level II-2)
13. Ogawa Y, Kaneko S, Otani K, Fukushima Y. Serum folic acid in epileptic mothers and their relationship to congenital malformations. Epilepsy Res 1991;8:75-78 (Level II-2)
14. Milunsky A, Jick H, Jick SS, Bruell CL, MacLaughlin DS, RothmanKJ, et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 1989;262:2847-2852 (Level II-2)
15. Centers for Disease Control and Prevention. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR 1992;41(RR14):1-7 (Level III)
16. Rosa FW. Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med 1991;324: 674-677 (Level II-2)
17. Lindhout D, Schmidt D. In-utero exposure to valproate and neural tube defects. Lancet 1986;2:1392-1393 (Level II-2)
18. Yerby MS, Leavitt A, Erickson DM, McCormick KB, Loewenson RB, Sells CJ, et al. Antiepileptics and the development of congenital anomalies. Neurology 1992;42(Suppl 5): 132-140 (Level II-2)
19. Mountain KR, Hirsh J, Gallus AS. Neonatal coagulation defect due to anticonvulsant drug treatment in pregnancy. Lancet 1970:1:265-268 (Level II-2)
20. Bleyer WA, Skinner AL. Fatal neonatal hemorrhage after maternal anticonvulsant therapy. JAMA 1976;235:626-627 (Level II-3)
21. Delgado-Escueta AV, Janz D. Consensus guidelines: preconception counseling, management, and care of the pregnant woman with epilepsy. Neurology 1992; 42(Suppl 5): 149-160 (Level III)
22. Cornelissen M, Steegers-Theunissen R, Kollée L, Eskes T, Motohara K, Monnens L. Supplementation of vitamin K in pregnant women receiving anticonvulsant therapy prevents neonatal vitamin K deficiency. Am J Obstet Gynecol 1993:168:884-888 (Level II-2)
23. Friis B, Sardemann H. Neonatal hypocalcaemia after intrauterine exposure to anticonvulsant drugs. Arch Dis Child 1977;52:239-247 (Level II-3)
24. Nakane Y, Okuma T, Takahashi R, Sato Y, WadaT, Sato T, et al. Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in Japan. Epilepsia 1980;21:663-680 (Level II-2)
25. Kaneko S, Otani K, Fukushima Y, Ogawa Y, Nomura Y, Ono T, et al. Teratogenicity of antiepileptic drugs: analysis of possible risk factors. Epilepsia 1988;29:459-467 (Level II-2)
26. Koch S, Lösche G, Jager-Romän E, Jakob S, Rating D, Deichl A, et al. Major and minor birth malformations and antiepileptic drugs. Neurology 1992;42(Suppl 5):83-88 (Level II-2)
27. Hanson JW, Smith DW. The fetal hydantoin syndrome. J Pediatr 1975;87:285-290 (Level II-3)
28. Hanson JW, Myrianthopoulos NC, Harvey MAS, Smith DW, Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. J Pediatr 1976;89:662-668 (Level II-3 and Level II-2)
29. Gaily E, Granström M-L, Hiilesmaa V, Bardy A. Minor anomalies in offspring of epileptic mothers. J Pediatr 1988; 112:520-529 (Level II-2)
30. Kelly TE, Rein M, Edwards P. Teratogenicity of anticonvulsant drugs. IV. The association of clefting and epilepsy. Am J Med Genet 1984;19:451-458 (Level II-2)
31. Friis ML, Holm NV, Sindrup EH, Fogh-Andersen P, Hauge M. Facial clefts in sibs and children of epileptic patients. Neurology 1986;36:346-350 (Level II-2)
32. Hecht JT, Annegers JF, Kurland LT. Epilepsy and clefting disorders: lack of evidence of a familial association. Am J Med Genet 1989;33:244-247 (Level II-2)
33. DiLiberti JH, Farndon PA, Dennis NR, Curry CJR. The fetal valproate syndrome. Am J Med Genet 1984;19:473-481 (Level II-3)
34. Ardinger HH, Atkin JF, Blackston RD, Elsas LJ, Clarren SK, Livingstone S, et al. Verification of the fetal valproate syndrome phenotype. Am J Med Genet 1988;29:171-185 (Level II-3)
35. Jäger-Roman E, Deichl A, Jakob S, Hartmann A-M, Koch S, Rating D, et al. Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid. J Pediatr 1986;108:997-1004 (Level II-2)
36. Wegner C, Nau H. Alteration of embryonic folate metabolism by valproic acid during organogenesis: implications for mechanism of teratogenesis. Neurology 1992;42(Suppl 5): 17-24 (Level I)
37. Jones KL, Lacro RV, Johnson KA, Adams J. Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 1989;320: 1661-1666 (Level II-2)
38. Finnell RH, Buehler BA, Kerr BM, Ager PL, Levy RH. Clinical and experimental studies linking oxidative metabolism to phenytoin-induced teratogenesis. Neurology 1992;42(Suppl 5):25-31 (Level I-2)
39. Desmond MM, Schwanecke RP, Wilson GS, Yasunaga S, Burgdorff I. Maternal barbiturate utilization and neonatal withdrawal symptomatology. J Pediatr 1972;80:190-197 (Level II-3)
40. Dessens AB, Boer K, Koppe JG, van de Poll NE, Cohen-Kettenis PT. Studies on long-lasting consequences of prenatal exposure to anticonvulsant drugs. Acta Paediatr Suppl 1994;404:54-64 (Level III)
41. Reinisch JM, Sanders, SA, Mortensen EL, Rubin DB. In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA 1995;274:1518-1525 (Level II-2)
42. Granström M-L, Gaily E. Psychomotor development in children of mothers with epilepsy. Neurology 1992;42(Suppl 5): 144-148 (Level III)
43. Annegers JF, Hauser WA, Elveback LR, Anderson VE, Kurland LT. Seizure disorders in offspring of parents with a history of seizures - a maternal-paternal difference? Epilepsia 1976;17:1-9 (Level II-2)
44. Yerby MS. Problems and management of the pregnant woman with epilepsy. Epilepsia 1987;28(Suppl 3):S29-S36 (Level III)
45. Kaneko S, Sato T, Suzuki K. The levels of anticonvulsants in breast milk. Br J Clin Pharmacol 1979;7:624-627 (Level II-3)
46. Knott C, Reynolds F, Clayden G. Infantile spasms on weaning from breast milk containing anticonvulsants. Lancet 1987;2:272-273 (Level III)